Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Reduced mitochondrial fusion and Huntingtin levels contribute to impaired dendritic maturation and behavioral deficits in Fmr1-mutant mice.

Shen M, Wang F, Li M, Sah N, Stockton ME, Tidei JJ, Gao Y, Korabelnikov T, Kannan S, Vevea JD, Chapman ER, Bhattacharyya A, van Praag H, Zhao X.

Nat Neurosci. 2019 Mar;22(3):386-400. doi: 10.1038/s41593-019-0338-y. Epub 2019 Feb 11.

PMID:
30742117
2.

Hippocampal deficits in neurodevelopmental disorders.

Li Y, Shen M, Stockton ME, Zhao X.

Neurobiol Learn Mem. 2018 Oct 12. pii: S1074-7427(18)30235-1. doi: 10.1016/j.nlm.2018.10.001. [Epub ahead of print]

PMID:
30321651
3.

Reducing histone acetylation rescues cognitive deficits in a mouse model of Fragile X syndrome.

Li Y, Stockton ME, Eisinger BE, Zhao Y, Miller JL, Bhuiyan I, Gao Y, Wu Z, Peng J, Zhao X.

Nat Commun. 2018 Jun 27;9(1):2494. doi: 10.1038/s41467-018-04869-3.

4.

MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome.

Li Y, Stockton ME, Bhuiyan I, Eisinger BE, Gao Y, Miller JL, Bhattacharyya A, Zhao X.

Sci Transl Med. 2016 Apr 27;8(336):336ra61. doi: 10.1126/scitranslmed.aad9370.

5.

Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells.

Stockton ME, Rasmussen K.

Psychopharmacology (Berl). 1996 Mar;124(1-2):50-6.

PMID:
8935800
6.
8.

Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.

Rasmussen K, Czachura JF, Stockton ME, Howbert JJ.

J Pharmacol Exp Ther. 1993 Jan;264(1):480-8.

PMID:
8423546
9.

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity.

Rasmussen K, Stockton ME, Czachura JF, Howbert JJ.

Eur J Pharmacol. 1991 Dec 10;209(1-2):135-8.

PMID:
1687681
10.

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons.

Rasmussen K, Stockton ME, Czachura JF.

Eur J Pharmacol. 1991 Nov 19;205(1):113-6.

PMID:
1811993
11.

NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.

Rasmussen K, Fuller RW, Stockton ME, Perry KW, Swinford RM, Ornstein PL.

Eur J Pharmacol. 1991 May 2;197(1):9-16.

PMID:
1832640
12.

Calcium activation of mougeotia potassium channels.

Lew RR, Serlin BS, Schauf CL, Stockton ME.

Plant Physiol. 1990 Mar;92(3):831-6.

13.

Red light regulates calcium-activated potassium channels in mougeotia plasma membrane.

Lew RR, Serlin BS, Schauf CL, Stockton ME.

Plant Physiol. 1990 Mar;92(3):822-30.

Supplemental Content

Loading ...
Support Center